Table 1.
Participant characteristics
| MDD (n = 58) | No MDD (n = 133) | Total sample (N = 191) | |
|---|---|---|---|
| Age | |||
| Years | 43.3 (6.5) | 45.0 (7.8) | 44.5 (7.5) |
| Sex (% male) | 58.6 | 66.9 | 64.4 |
| Ethnicity (%) | |||
| African American | 41.4 | 54.9 | 50.8 |
| Hispanic or Latino | 31.0 | 20.3 | 23.6 |
| Caucasian | 27.6 | 22.6 | 24.1 |
| Other | 0 | 2.3 | 1.6 |
| Education (years) | 11.8 (3.0) | 12.4 (2.8) | 12.2 (2.9) |
| WRAT-3 (SS) | 83.3 (18.9) | 86.9 (17.4) | 85.8 (17.9) |
| Length of HIV infection, years | 9.9 (4.9) | 11.6 (5.3)* | 11.1 (5.2) |
| Antiretroviral medication (%) | 65.5 | 78.9* | 74.9 |
| Detectable HIV RNA (%) | 68.8 | 76.1 | 73.9 |
| Median CD4, cells/μL | 149 | 168 | 165 |
| CD4 (cells/μL) (%) | |||
| ≥ 500 | 20.0 | 21.4 | 21.0 |
| 200–499 | 24.0 | 23.9 | 24.0 |
| ≤ 199 | 56.0 | 54.7 | 44.9 |
| Substance dependence, current (%) | |||
| Alcohol | 12.1 | 12.0 | 12.0 |
| Cannabis | 12.1 | 5.3 | 7.3 |
| Cocaine | 27.6 | 17.3 | 20.4 |
| Opiate | 12.1 | 5.3 | 7.3 |
| Peripheral neuropathy (%) | 46.4 | 47.3 | 47.1 |
| Antidepressant medication (%) | 36.2 | 27.1 | 29.8 |
Note. WRAT-3 (SS) is Wide Range Achievement Test – 3rd Edition reading standard score; means and standard deviations are presented unless otherwise indicated.
*
p < .05